New technique scours the genome for genes that combat diseaseOctober 12, 2017
Using a modified version of the CRISPR genome-editing system, MIT researchers have developed a new way to screen for genes that protect against specific diseases.
CRISPR is normally used to edit or delete genes from living cells. However, the MIT team adapted it to randomly turn on or off distinct gene sets across large populations of cells, allowing the researchers to identify genes that protect cells from a protein associated with Parkinson's disease.
The new technology, described in the journal Molecular Cell, offers a new way to seek drug targets for many diseases, not just Parkinson's, says Timothy Lu, an MIT associate professor of electrical engineering and computer science and of biological engineering.
"The state of the art right now is targeting two or three genes simultaneously and then looking at the effects, but we think that perhaps the gene sets that need to be modulated to address some of these diseases are actually broader than that," says Lu, who is the senior author of the study.
The paper's lead authors are postdoc Ying-Chou Chen and graduate student Fahim Farzadfard.
Turning genes on or off
The CRISPR genome-editing system consists of a DNA-cutting enzyme called Cas9 and short RNA guide strands that target specific sequences of the genome, telling Cas9 where to make its cuts. Using this process, scientists can make targeted mutations in the genomes of living animals, either deleting genes or inserting new ones.
In the new study, the MIT team deactivated Cas9's cutting ability and engineered the protein so that after binding to a target site, it recruits transcription factors (proteins that are required to turn genes on).
By delivering this version of Cas9 along with the guide RNA strand into single cells, the researchers can target one genetic sequence per cell. Each guide RNA might hit a single gene or multiple genes, depending on the particular guide sequence. This allows researchers to randomly screen the entire genome for genes that affect cell survival.
"What we decided to do was take a completely unbiased approach where instead of targeting individual genes of interest, we would express randomized guides inside of the cell," Lu says. "Using that approach, can we screen for guide RNAs that have unusually strong protective activities in a model of neurodegenerative disease."
The researchers deployed this technology in yeast cells that are genetically engineered to overproduce a protein associated with Parkinson's disease, known as alpha-synuclein. This protein, which forms clumps in the brains of Parkinson's patients, is normally toxic to yeast cells.
Using this screen, the MIT team identified one guide RNA strand that had a very powerful effect, keeping cells alive much more effectively than any of the individual genes that have been previously found to protect this type of yeast cell.
Further genetic screening revealed that many of the genes turned on by this guide RNA strand are chaperone proteins, which help other proteins fold into the correct shape. The researchers hypothesize that these chaperone proteins may assist in the proper folding of alpha synuclein, which could prevent it from forming clumps.
Other genes activated by the guide RNA encode mitochondrial proteins that help cells regulate their energy metabolism, and trafficking proteins that are involved in packaging and transporting other proteins. The researchers are now investigating whether the guide RNA turns on each of these genes individually or whether it activates one or more regulatory genes that then turn the others on.
Once the researchers identified these genes in yeast, they tested the human equivalents in human neurons, grown in a lab dish, that also overproduce alpha synuclein. These human genes were also protective against alpha-synuclein-induced death, suggesting that they could be worth testing as gene therapy treatments for Parkinson's disease, Lu says.
Lu's lab is now using this approach to screen for genes related to other disorders, and the researchers have already identified some genes that appear to protect against certain effects of aging.
Massachusetts Institute of Technology
Related Genome Articles:
An international consortium, with the participation of the Helmholtz Zentrum München, Plant Genome and Systems Biology Department (PGSB), has published methodologically significant data on the barley genome.
Looking for a better beer or single malt Scotch whiskey?
Chronic lung infections can be devastating for patients with cystic fibrosis (CF), and infection by Burkholderia cenocepacia, one of the most common species found in cystic fibrosis patients, is often antibiotic resistant.
Cells face a daunting task. They have to neatly pack a several meter-long thread of genetic material into a nucleus that measures only five micrometers across.
A study by San Diego Zoo Global reveals that the prospects for recovery of the critically endangered northern white rhinoceros -- of which only three individuals remain -- will reside with the genetic resources that have been banked at San Diego Zoo Global's Frozen Zoo®.
Precise, economical genome editing tools such as CRISPR have made it possible to make targeted changes in genes, which could be applied to human embryos to correct mutations, prevent disease, or alter traits.
How do pathogens such as bacteria or parasites manage to hide from their host's immune system?
An international team of scientists, led by researchers from A*STAR's Genome Institute of Singapore and the Bioinformatics Institute, have developed SIFT 4G (SIFT for Genomes) -- a software that can lead to faster genome analysis.
Single-cell techniques have been used to investigate histone replacement and chromatin remodeling in developing oocytes.
Dinoflagellates live free-floating in the ocean or symbiotically with corals, serving up -- or as -- lunch to a host of mollusks, tiny fish and coral species.
Related Genome Reading:
Genome (The Extinction Files Book 2)
by A.G. Riddle (Author)
The thrilling conclusion to THE EXTINCTION FILES is finally here!
* * *
A code hidden in the human genome...
Will reveal the ultimate secret of human existence.
And could hold humanity's only hope of survival.
* * *
In 2003, the first human genome was sequenced. But the secrets it held were never revealed.
The truth was discovered thirty years ago, almost by accident. Dr. Paul Kraus had spent his entire career searching for what he called humanity's lost tribes--human ancestors who had gone extinct. When... View Details
Genome: The Autobiography of a Species in 23 Chapters
by Matt Ridley (Author)
The genome's been mapped.
But what does it mean?
Arguably the most significant scientific discovery of the new century, the mapping of the twenty-three pairs of chromosomes that make up the human genome raises almost as many questions as it answers. Questions that will profoundly impact the way we think about disease, about longevity, and about free will. Questions that will affect the rest of your life.
Genome offers extraordinary insight into the ramifications of this incredible breakthrough. By picking one newly discovered gene from each pair of chromosomes and... View Details
Adam and the Genome: Reading Scripture after Genetic Science
by Scot McKnight (Author), Dennis R. Venema (Author), Daniel Harrell (Afterword), Tremper Longman III (Afterword)
Genomic science indicates that humans descend not from an individual pair but from a large population. What does this mean for the basic claim of many Christians: that humans descend from Adam and Eve?
Leading evangelical geneticist Dennis Venema and popular New Testament scholar Scot McKnight combine their expertise to offer informed guidance and answers to questions pertaining to evolution, genomic science, and the historical Adam. Some of the questions they explore include:
- Is there credible evidence for evolution?
- Do we descend from a population or are we the offspring of... View Details
The Gene: An Intimate History
by Siddhartha Mukherjee (Author)
THE #1 NEW YORK TIMES BESTSELLER
A New York Times Notable Book
A Washington Post and Seattle Times Best Book of the Year
From the Pulitzer Prize-winning author of The Emperor of All Maladies—a fascinating history of the gene and “a magisterial account of how human minds have laboriously, ingeniously picked apart what makes us tick” (Elle).
“Dr. Siddhartha Mukherjee dazzled readers with his Pulitzer Prize-winning The Emperor of All Maladies in 2010. That achievement was evidently just a warm-up for... View Details
Genetics: From Genes to Genomes, 5th edition
by Leland H. Hartwell (Author), Michael L. Goldberg (Author), Janice A. Fischer (Author), Leroy Hood (Author), Charles F. Aquadro (Author)
Genetics: From Genes to Genomes is a cutting-edge, introductory genetics text authored by an unparalleled author team, including Nobel Prize winner, Leland Hartwell. The 5th edition continues to build upon the integration of Mendelian and molecular principles, providing students with the links between the early understanding of genetics and the new molecular discoveries that have changed the way the field of genetics is viewed.
Users who purchase Connect Plus receive access to the full online ebook version of the textbook as well as SmartBook. View Details
The Genome War: How Craig Venter Tried to Capture the Code of Life and Save the World
by James Shreeve (Author)
The long-awaited story of the science, the business, the politics, the intrigue behind the scenes of the most ferocious competition in the history of modern science—the race to map the human genome.
On May 10, 1998, biologist Craig Venter, director of the Institute for Genomic Research, announced that he was forming a private company that within three years would unravel the complete genetic code of human life—seven years before the projected finish of the U.S. government’s Human Genome Project. Venter hoped that by decoding the genome ahead of schedule, he would speed up the pace of... View Details
The Developing Genome: An Introduction to Behavioral Epigenetics
by David S. Moore (Author)
Why do we grow up to look, act, and feel as we do? Through most of the twentieth century, scientists and laypeople answered this question by referring to two factors alone: our experiences and our genes. But recent discoveries about how genes work have revealed a new way to understand the developmental origins of our characteristics. These discoveries have emerged from the new science of behavioral epigenetics--and just as the whole world has now heard of DNA, "epigenetics" will be a household word in the near future.
Behavioral epigenetics is important because it explains how our... View Details
by A. G. Riddle (Author)
From the author of the #1 bestselling The Atlantis Gene comes a new novel in which the world’s past and future rests in the hands of five unwitting strangers in this definitive edition of A. G. Riddle's time-traveling, mind-bending speculative thriller.
En route to London from New York, Flight 305 suddenly loses power and crash-lands in the English countryside, plunging a group of strangers into a mysterious adventure that will have repercussions for all of humankind.
Struggling to stay alive, the survivors soon realize that the world they’ve... View Details
The Deeper Genome: Why there is more to the human genome than meets the eye
by John Parrington (Author)
Over a decade ago, as the Human Genome Project completed its mapping of the entire human genome, hopes ran high that we would rapidly be able to use our knowledge of human genes to tackle many inherited diseases, and understand what makes us unique among animals. But things didn't turn out that way. For a start, we turned out to have far fewer genes than originally thought -- just over 20,000, the same sort of number as a fruit fly or worm. What's more, the proportion of DNA consisting of genes coding for proteins was a mere 2%. So, was the rest of the genome accumulated 'junk'?... View Details
Neanderthal Man: In Search of Lost Genomes
by Svante Pääbo (Author)
"[T]his book is a vibrant testimonial to what might be the greatest creation of modern humans: the scientific method." --Salon
Neanderthal Man tells the story of geneticist Svante Pääbo's mission to answer this question: what can we learn from the genomes of our closest evolutionary relatives? Beginning with the study of DNA in Egyptian mummies in the early 1980s and culminating in the sequencing of the Neanderthal genome in 2010, Neanderthal Man describes the events, intrigues, failures, and triumphs of these scientifically rich years through the lens of... View Details